Australia markets open in 9 hours 4 minutes

Salarius Pharmaceuticals, Inc. (SLRX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8539+0.0139 (+1.65%)
As of 9:54AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.8400
Open0.8374
Bid0.8301 x 900
Ask0.8400 x 1100
Day's range0.8300 - 0.8539
52-week range0.6320 - 3.5000
Volume121,771
Avg. volume1,276,941
Market cap38.237M
Beta (5Y monthly)1.85
PE ratio (TTM)N/A
EPS (TTM)-0.3090
Earnings date09 Nov 2021 - 15 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.63
  • GlobeNewswire

    Salarius Pharmaceuticals to Report Third Quarter 2021 Financial Results and Highlight Recent Company Progress

    Conference Call and Live Audio Webcast Scheduled for Thursday, November 4, 2021, 5:00 p.m. ETHOUSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, today announced that the Company will host a conference call and live audio webcast on Thursday, November 4, 2021, at 5:00 p.m. ET, to discuss its corpo

  • GlobeNewswire

    Salarius Pharmaceuticals and Nationwide Children’s Hospital Disclose Research Findings from Presentation at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

    HOUSTON, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, and Nationwide Children’s Hospital announced today research findings from their presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics. The conference begins today, October 7, 2021, and runs through

  • GlobeNewswire

    Salarius Pharmaceuticals to Present at the 2021 BioFuture Conference

    HOUSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, announced today that David Arthur, Chief Executive Officer, will present virtually at the 2021 BioFuture Conference. The event will be held in New York City on October 5-6, 2021, at Cure, Deerfield Management Company’s vertical healthcare-dedica